NSECertificate under SEBI (Depositories and Participants) Regulations, 20181d ago · 13 Oct 2026, 02:03 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Marksans Pharma Limited · MARKSANS

✦ AI Summary

Marksans Pharma Limited has received a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities up to September 30, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Marksans Pharma Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter and half year ended September 30, 2026

Attachments (1)

📄

MARKSANS_13102026140319_SEintimation.pdf

pdf

Download →
View document text
Date: October 13, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai - 400001. Bandra (East), Mumbai - 400051. Scrip Code: 524404 Symbol: MARKSANS Sub: Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Dear Sir/Madam, Kindly find enclosed herewith the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended September 30, 2026 received from Bigshare Services Private Limited, Registrar and Transfer Agent of the Company. You are requested to note the above in your records. Thanking You. Yours faithfully, For Marksans Pharma Limited Harshavardhan Panigrahi Company Secretary Encl: As Above Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com Ref No. BSS/74(5) Date: 09/10/2026 MARKSANS PHARMA LTD FV 1 11TH FLOOR, GRANDEUR VEERA DESAI, EXTENSION ROAD OSHIWARA, ANDHERI WEST MUMBAI 400053 Dear Sir/Madam, Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026. Ref: NSDL/CIR/II/5/2019 dated 25th January 2019 DSL/OPS/RTA/POLICY/2019/14 dated 25th January 2019. SEBI vide its letter ref no. MRD/DOP2/DSA2/OW/2019/2498/1 dated 24/01/2019 In reference to the above – captioned regulation we hereby confirm that the securities received from the depository Participants for dematerialization up to 30th September 2026 were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchange where the earlier issued securities are listed. We hereby confirm that the security certificates received for dematerialization have been mutilated & cancelled after due verification by the depository Participant and the name of the depositories have been substituted in register of members as registered owner within 15 days of receipt of certificate of securities. We request you to kindly take note of the above in your records. Thanking you, Yours faithfully, For BIGSHARE SERVICES PVT LTD. Sandeep More Authorised Signatory. CIN – U99999MH1994PTC076534 Regd. Office: Office No. S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road, Andheri (EAST), Mumbai – 400 093. Email: info@bigshareonline.com | Tel. No. +91-22-62638200| website: www.bigshareonline.com